Veeda Clinical Research Limited completes acquisition of Heads to expand global reach and capabilities
Acquiring Company
Veeda Clinical Research Limited
Acquired Company
Heads
Description
Veeda Clinical Research Limited, a full-service contract research organization, has acquired Heads, a European CRO specializing in conducting clinical trials in oncology. With this acquisition, Veeda enters the league of global CROs with integrated capabilities to extend contract research services from discovery to clinical development extending to post commercial launch.
Quick answer
Veeda Clinical Research Limited is acquiring Heads, announced March 26, 2024. Veeda Clinical Research Limited is based in Ahmedabad, Gujarat, India.
- How much did Veeda Clinical Research Limited pay for Heads?
- The deal value was not disclosed.
- What does Veeda Clinical Research Limited do?
- Veeda Clinical Research Limited is one of the largest independent, full-service clinical research organizations, headquartered in Ahmedabad, India.
- Where are Veeda Clinical Research Limited and Heads based?
- Veeda Clinical Research Limited is based in Ahmedabad, Gujarat, India. Heads is based in Dublin, Dublin, Ireland.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- Reverba completes acquisition of Six Degrees Worldwide Inc. to integrate medical communication services (April 3, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- Integrated Oncology Network completes acquisition of Urology Partners, LLC to expand urologic healthcare services (May 2, 2024)
Who to call at Veeda Clinical Research Limited, and when
When Veeda Clinical Research Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Veeda Clinical Research Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Veeda Clinical Research Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Veeda Clinical Research Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Veeda Clinical Research Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Heads?
Heads was acquired by Veeda Clinical Research Limited, based in Ahmedabad. The deal was reported on March 26, 2024. Veeda Clinical Research Limited is one of the largest independent, full-service clinical research organizations, headquartered in Ahmedabad, India. Veeda Clinical Research Limited is privately held and operates in Biotechnology.
When did Veeda Clinical Research Limited acquire Heads?
Veeda Clinical Research Limited's acquisition of Heads was reported on March 26, 2024. Veeda Clinical Research Limited, a full-service contract research organization, has acquired Heads, a European CRO specializing in conducting clinical trials in oncology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Heads do?
Heads is a full-service Global Contract Research Organization (CRO) dedicated to the conduct of clinical studies, with expertise in haemato-oncology studies. It is privately held, operating in Health Care, and is based in Dublin.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.